Note: Ingredients listed on restricted chemical lists
EC/CAS
247-714-0/26447-40-5
Name of the chemical
Methylenediphenyl diisocyanate (see also specific isomers)
Concentration
<25%
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
5 %
EC/CAS
5873-54-1
Name of the chemical
2,4’-Methylenediphenyl diisocyanate
Concentration
<0,4%
EC/CAS
247-722-4/26471-62-5
Name of the chemical
m-Tolylidendiisocyanat
Concentration
N/A
EC/CAS
584-84-9
Name of the chemical
2,4-Diisocyanattoluol
Concentration
0,1 %
EC/CAS
91-08-7
Name of the chemical
2,6-Diisocyanattoluol
Concentration
N/A
General Information
Version
3.0/EN
Revision date
2023-05-24
Product name
TETRAPUR 135 COMPONENT B
1.2.1 Relevant identified uses
adhesive for bonding mineral aggregates
1.2.2. Uses advised against
not determinate
Manufacturer Name
BSG Sp. z o. o
Icons in SDS
Company Information
company name
BSG Sp. z o. o
e-mail address of the competent person responsible for the Safety Data Sheet
biuro@thetaconsulting.pl
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H332, H334, H335, H351, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Skin Irrit. 2 H315, Skin Sens. 1 H317, Eye Irrit. 2 H319, Acute Tox. 4 H332, Resp. Sens. 1 H334, STOT SE 3 H335, Carc. 2 H351, STOT RE 2 H373 Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Harmful if inhaled. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause respiratory irritation. Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure through inhalation.
2.2 Label elements
Hazard pictograms and signal words DANGER Names of dangerous components placed on label
Contains
methylenediphenyl diisocyanate; m-tolylidene diisocyanate.
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure through inhalation. TETRAPUR 135 COMPONENT B p. 1/10
Precautionary statements
P201 Obtain special instructions before use. P280 Wear protective gloves/protective clothing/eye protection/face protection. P284 In case of inadequate ventilation wear respiratory protection. P302+P352 IF ON SKIN: Wash with plenty of water. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P308+P313 IF exposed or concerned: Get medical advice/attention. P501 Dispose of contents/container to properly labeled containers for selective waste collection emptied by an authorised company.
Additional information
As from 24 August 2023 adequate training is required before industrial or professional use
2.3 Other hazards
The components do not meet the criteria for PBT or vPvB in accordance with Annex XIII of Regulation REACH. The product reacts with water with emission of carbon dioxide which can burst sealed containers. At higher temperatures the reaction is accelerated. The product does not contain substances included in the list established in accordance with Article 59(1) for having endocrine disrupting properties, or substances identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % by weight. Se ction 3: Com position/inform ation on ingre die nts
